Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 181,100 shares, a growth of 12.1% from the February 29th total of 161,500 shares. Based on an average daily trading volume, of 115,700 shares, […]
Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) CEO Scott Hutton sold 29,708 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $1.66, for a total transaction of $49,315.28. Following the transaction, the chief executive officer now directly owns 465,011 shares in the company, […]
MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 178,000 shares, a growth of 237.8% from the December 15th total of 52,700 shares. Based on an average trading volume of 38,700 shares, […]
Roth Mkm started coverage on shares of Forian (NASDAQ:FORA – Free Report) in a research report sent to investors on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $5.00 price target on the stock. Separately, Royal Bank of Canada boosted their price target on shares of Forian from $11.00 to […]
Addison Capital Co lowered its position in Cano Health, Inc. (NYSE:CANO – Get Rating) by 37.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 294,870 shares of the company’s stock after selling 179,750 shares during the period. Addison Capital Co’s […]